Ex Vivo Mechanism of Action (MoA) and Pharmacokinetic (PK) Immune Assays
Accelevir’s ex vivo immune assays bridge the gap between in vitro potency and in vivo efficacy. We provide MoA assays for therapeutic immune cell function, combined with immune PK assays to track persistence, distribution, and clearance in biological matrices.
Technical Capabilities:
- Ex vivo killing, cytokine secretion, and proliferation assays.
- PK analysis for therapeutic antibodies, cytokines, or cell products.
- Vector genome persistence tracking via qPCR/dPCR.
- GLP-compliant sample processing and reporting.
Why Partner with Accelevir:
- Integration of PK data with immune activation and functional potency.
- Cross-platform expertise for cell therapy, gene therapy, and biologics.